Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
the submission that was just submitted on the 6th was with Empirical, they partnered with them in 2021 and completed the submission in 2022, is that bad? i mean, i would want them to get their shit together before submitting again and being rejected. IDC how long it takes if its more likely to guarantee an approval
i understand your frustration and the background neglect from the management to update shareholders etc....but what happens when/if they get FDA approval, then they have a niche product with a huge marketplace, isn't that worth betting on?
The "orders" are for third party cpap machines. They can't sell the DeltaWave until the 510k is cleared by the FDA. The company is currently valued at over $50 million dollars which is ABSURD when the same third party cpap machines are a dime a dozen all over the internet.
correct, just mentioned that in my last reply, empirical is definitely reassuring
still going back over 2 years ago, has any management changed since then? partnering with empirical tech for their submission seems reassuring. they have a great track record. still seems like a low risk/high reward play to me
Let’s not forget they brought in a company with 100% track record of getting 510k’s approved.
I mean, it gives some context and background, but, two years later and a newly submitted 510k, you don't think any kinks were worked out? still seems its just a matter of time. they have actual orders dont they? anything in OTC is speculation and a pipedream but i think the fundamentals are still in play as long as the management is transparent
Insane dilution, three-card monte CEO played with the 510k, shady antics with the Twitter account: CEO claimed their original Twitter account that was used to pump the stock so noteholders could dump was fake. They deleted it and started a new account....
https://www.globenewswire.com/news-release/2020/01/27/1975547/0/en/REMSleep-Holdings-Inc-Issues-Statement-Clarifying-Unauthorized-Twitter-Post-and-Account.html
Great factual post… so glad you have been able to show us the process of a 510k approval. With the continued 52 week highs anybody that listened to your posts would have missed out on profit!
You were bullish back in 2019-2020, whats changed with the company or device for you to become so bearish? the amount of time its taken for the PMA 510k?
hell yea scooping more today
FDA approval next week!!!
Loaded up some more here in the low .03s. I think the chart will turn up tomorrow. MMs will likely keep it down here for the rest of the day.
It's certainly possible given the huge amount of pre FDA approval accumulation we have seen these past few weeks.
Did Big Momma hear 10 cents in the near future?
.10 is certainly possible but I think it will take FDA approval decision to get it there. But you can clearly see huge interest as we head into the early June timeframe. Could see .05 area and maybe base there until the decision is announced.
Could run to .10 before FDA approval this month early June !!
Two weeks?....HahahaOver SEVEN YEARS promising 510k.
Read their PR history and filings since 2015 to see the history of BS unfulfilled promises and completely inept management.
Best part. Two weeks away
The Company also has a 510(k) submission for its DeltaWave CPAP MASK with the FDA and expects a decision in the next 2 weeks. RMSL has a fast-growing shareholder base; ready liquidity and the $0.048 highs of summer 2021 in its sights, a break over and its blue skies ahead for RMSL.
ASCM is here. We have your attention. This is the next AABB
Don’t be without shares for the FDA run and revenue
Patent is worth ZERO without 510k clearance.
RMSL only has one patent, the DeltaWave they have been trying to get 510k FDA cleared for over seven years.
They have patents myster Pay the ask. To the moon!!
The next AABB
Could get crazy here next week
Best day in the last 12 months?
FDA approval on its way. Toms last patents did over $200 million in sales I believe. This will surpass that. IMO GLTA
Starting to look much better here! GLTA
New 52 week high. Where or where is the common bear
Interest is really starting to grow here. Closed .035, very bullish what lies ahead.
Wait was that supposed to be mean or something? Or did you run out of information for me to dispute.
Credibility is the name of the game.
Pumpers have a lot in common with the CEO.
Not sure if you read the 10q in full or not the potential dilution that remains is less then 10% of the current share structure.
Myself personally could care less about the warrants or last remaining convertible note.
Since the beginning of the year RMSL is up over 100%+ and this might shock some but in order for a pre-revenue company to finance their growth they have to take on debt including dilution.
There has not been any recent debt added and the offering in fact was closed early because they have all the funding needed to move into revenue and profit generating.
It’s up to you but RMSL is the best play not just in the otc but market wide!
No mention to the "Team" that noteholders were dumping on the "offering closed" pump tweets which implied no more dilution. Only mentioned the notes after they've mostly been converted even though convertible notes are 10x more dilutive than an offering due to the heinous conversion rates.
Dilution is dilution is dilution....
Wait for the "Warrants done!" post....
Lol that’s your last argument… warrants from the passed… great let them all be converted… this company is stacked up perfectly. Keep reaching for a reason not to make money because you won’t find it.
Followers
|
312
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |